ANI Pharmaceuticals Inc
ANIP· Nasdaq
ANI Pharmaceuticals Inc
- Last sale
- Oct 2, 2026 · -0.77%
- Market cap
- $1.63B
- 22.49M shares
- Filings
- 1,037
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $883,366,000 | reported | |
| FY 2024 | 2024-12-31 | $614,376,000 | reported | |
| FY 2023 | 2023-12-31 | $486,816,000 | reported | |
| FY 2022 | 2022-12-31 | $316,385,000 | reported | |
| FY 2021 | 2021-12-31 | $216,136,000 | reported | |
| FY 2020 | 2020-12-31 | $208,475,000 | reported | |
| FY 2019 | 2019-12-31 | $206,547,000 | reported | |
| FY 2018 | 2018-12-31 | $201,576,000 | reported | |
| FY 2017 | 2017-12-31 | $176,842,000 | reported | |
| FY 2016 | 2016-12-31 | $128,622,000 | reported | |
| FY 2015 | 2015-12-31 | $76,322,000 | reported | |
| FY 2014 | 2014-12-31 | $55,970,000 | reported |
ANI Pharmaceuticals Inc · CIK 1023024 · Engraved from SEC EDGAR
